SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-237790
Filing Date
2021-08-05
Accepted
2021-08-05 16:33:34
Documents
14

Document Format Files

Seq Description Document Type Size
1 F-3 d159178df3.htm F-3 594772
2 EX-1.2 d159178dex12.htm EX-1.2 223541
3 EX-4.3 d159178dex43.htm EX-4.3 175458
4 EX-4.4 d159178dex44.htm EX-4.4 976768
5 EX-5.1 d159178dex51.htm EX-5.1 55778
6 EX-23.1 d159178dex231.htm EX-23.1 1701
7 GRAPHIC g159178dsp0017.jpg GRAPHIC 2612
8 GRAPHIC g159178dsp5.jpg GRAPHIC 5565
9 GRAPHIC g159178g05a44.jpg GRAPHIC 45879
10 GRAPHIC g159178g0802135947541.jpg GRAPHIC 2582
11 GRAPHIC g159178g32e42.jpg GRAPHIC 46442
12 GRAPHIC g159178g60i01.jpg GRAPHIC 5106
13 GRAPHIC g159178g77x26.jpg GRAPHIC 46442
14 GRAPHIC g159178page40.jpg GRAPHIC 5808
  Complete submission text file 0001193125-21-237790.txt   2251177
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-258495 | Film No.: 211148904
SIC: 2834 Pharmaceutical Preparations